Article
Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer.
JAMA network open - 3 Sept 2024
Rezoug Zoulikha, Totten Stephanie P, Szlachtycz David, Atayan Adrienne, Mohler Kristen, Albert Sophie, Feng Leila, Lemieux Anglin Brianna, Shen Zhen, Jimenez Daniel, Hamel Nancy, Meti Nicholas, Esfahani Khashayar, Boileau Jean-François, Prakash Ipshita, Basik Mark, Meterissian Sarkis, Tremblay Francine, Fleiszer David, Anderson Dawn, Chong George, Wong Stephanie M, Foulkes William D
Abstract excerpt
Importance: Between 5% and 10% of breast cancer cases are associated with an inherited germline pathogenic or likely pathogenic variant (GPV) in a breast cancer susceptibility gene (BCSG), which could alter local and systemic therapy recommendations. Traditional genetic testing criteria misses a proportion of these cases. Objective: To evaluate the prevalence and clinicopathological associations of GPVs in 2...
Topics
- Humans
- Female
- Middle Aged
- Breast Neoplasms
- Genetic Testing
- Cross-Sectional Studies
- Adult
- Genetic Predisposition to Disease
- Aged
